Sancilio Pharmaceuticals Company, which markets, licenses and develops products based on its lipid drug delivery technology, filed on Monday with the SEC to raise up to $86 million in an initial public offering. The Riviera Beach, FL-based company, which...read more
Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its...read more
Catabasis Pharmaceuticals, which is developing combined therapies for Duchenne muscular dystrophy and high cholesterol, raised $60 million by offering 5 million shares (upsized from 4.3 million shares) at $12, below the range of $13 to $15. Catabasis...read more
17 companies are on the calendar to go public this week and raise $2.5 billion. It should be the year's most active week in the IPO market; the second busiest week saw 10 IPOs in...read more
Lipid drug delivery: Sancilio Pharmaceuticals files for an $86 million IPO
Sancilio Pharmaceuticals Company, which markets, licenses and develops products based on its lipid drug delivery technology, filed on Monday with the SEC to raise up to $86 million in an initial public offering. The Riviera Beach, FL-based company, which...read more
US IPO Weekly Recap: Year's hottest deal pops 186% in year's most active week with 13 IPOs
Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its...read more
Catabasis Pharmaceuticals prices IPO at $12, below the range
Catabasis Pharmaceuticals, which is developing combined therapies for Duchenne muscular dystrophy and high cholesterol, raised $60 million by offering 5 million shares (upsized from 4.3 million shares) at $12, below the range of $13 to $15. Catabasis...read more
Week ahead: As many as 17 IPOs could price during the week of June 22
17 companies are on the calendar to go public this week and raise $2.5 billion. It should be the year's most active week in the IPO market; the second busiest week saw 10 IPOs in...read more